4
Changes in Ownership
Solid Biosciences Inc. Filed Acc 0001193125-26-057863
Chief Operating Officer sold 7,469 shares at $5.82 ($43,494)
- Chief Operating Officer acquired 14,687 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Howton David T Chief Operating Officer | 2026-02-13 | Option exercise 10b5-1 | +14,687 | 112,546 | D | ||
| Howton David T Chief Operating Officer | 2026-02-18 | Sale 10b5-1 | −7,469 | $5.82 | $43,494 | 105,077 | D |
| Derivatives | |||||||
| Howton David T Chief Operating Officer | 2026-02-13 | Option exercise · Restricted Stock Units 10b5-1 | −14,687 | 29,376 | D | ||
| Open-market sales · 7,469 sh · avg $5.82 · $43,494 | |||||||
Loading xslF345X05/ownership.xml…